Attila Imre (SRI) presented a poster entitled: Early stage health economic evaluation of IMMUTOL gene Therapy for relapsing/remitting Multiple Sclerosis in the Netherlands at ISPOR Europe 2025, 9-12 November 2025, Glasgow, Scotland, UK.
Poto: SRI ISPORE 2025